Isabel Graupera

10.2k total citations · 3 hit papers
94 papers, 4.1k citations indexed

About

Isabel Graupera is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Isabel Graupera has authored 94 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 60 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Isabel Graupera's work include Liver Disease Diagnosis and Treatment (66 papers), Liver Disease and Transplantation (55 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Isabel Graupera is often cited by papers focused on Liver Disease Diagnosis and Treatment (66 papers), Liver Disease and Transplantation (55 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Isabel Graupera collaborates with scholars based in Spain, United States and France. Isabel Graupera's co-authors include Pere Ginès, María Poca, Càndid Villanueva, Elsa Solà, Virginia Hernández–Gea, Carles Aracil, Alan Colomo, Carlos Guarner, Mar Concepción and Alba Fernández Bosch and has published in prestigious journals such as Nature, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Isabel Graupera

87 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transfusion Strategies for Acute Upper Gastrointestinal Bleeding

2013 1.0k citations Càndid Villanueva, Alan Colomo et al. profile →
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

2021 171 citations Isabel Graupera, Llorenç Caballería et al. profile →
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

2023 116 citations Isabel Graupera, Pere Ginès et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Graupera Spain	33	2.4k	2.2k	1.2k	472	468	94	4.1k
Patrick G. Northup United States	38	3.7k 1.5×	3.0k 1.4×	2.3k 1.8×	89 0.2×	54 0.1×	122	5.2k
Domenico Ferro Italy	33	960 0.4×	1.2k 0.5×	779 0.6×	88 0.2×	200 0.4×	79	3.1k
Rakhi Maiwall India	30	1.8k 0.7×	1.6k 0.7×	722 0.6×	308 0.7×	21 0.0×	140	2.7k
Adrian J. Stanley United Kingdom	39	2.7k 1.1×	2.6k 1.2×	2.8k 2.2×	41 0.1×	58 0.1×	178	5.4k
J. Erhard Germany	22	598 0.2×	390 0.2×	929 0.7×	33 0.1×	253 0.5×	72	1.7k
Marigrazia Clerici Italy	22	1.2k 0.5×	976 0.4×	594 0.5×	52 0.1×	66 0.1×	65	2.6k
Hans Blokzijl Netherlands	24	673 0.3×	1.1k 0.5×	443 0.4×	104 0.2×	48 0.1×	103	2.1k
Denis Marleau Canada	25	1.6k 0.7×	1.2k 0.6×	1.1k 0.9×	70 0.1×	29 0.1×	55	2.0k
M. Burdelski Germany	40	3.0k 1.2×	1.3k 0.6×	3.8k 3.1×	66 0.1×	69 0.1×	189	5.5k
Ricardo Mastaï Argentina	27	2.0k 0.8×	1.6k 0.7×	1.2k 0.9×	151 0.3×	10 0.0×	69	2.6k

Countries citing papers authored by Isabel Graupera

Since Specialization

Citations

This map shows the geographic impact of Isabel Graupera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Graupera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Graupera more than expected).

Fields of papers citing papers by Isabel Graupera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Graupera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Graupera. The network helps show where Isabel Graupera may publish in the future.

Co-authorship network of co-authors of Isabel Graupera

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Graupera. A scholar is included among the top collaborators of Isabel Graupera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Graupera. Isabel Graupera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cervera, Marta, Martina Pérez, Marta Carol, et al.. (2025). Marked Variation in Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Over 5 Years: A Community‐Based Study Using Controlled Attenuation Parameter. United European Gastroenterology Journal. 13(10). 1946–1954. 1 indexed citations

Bertot, Luis Calzadilla, Anna Sòria, Isabel Badell, et al.. (2025). Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID‐LSM Model. Alimentary Pharmacology & Therapeutics. 62(5). 526–535.

Romero‐Gómez, Manuel, R. Aller, Javier Ampuero, et al.. (2023). AEEH "Consensus about detection and referral of hidden prevalent liver diseases". Gastroenterología y Hepatología (English Edition). 46(3). 236–247. 2 indexed citations

Arteaga, Íngrid, Alba Martínez-Escudé, Llorenç Caballería, et al.. (2023). Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol. PLoS ONE. 18(10). e0286586–e0286586. 7 indexed citations

Napoleone, Laura, Cristina Solé, Adrià Juanola, et al.. (2022). Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome. Hepatology Communications. 6(8). 2121–2131. 12 indexed citations

Carol, Marta, Martina Pérez, Elsa Solà, et al.. (2022). Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life. PLoS ONE. 17(4). e0265153–e0265153. 23 indexed citations

Graupera, Isabel, Mar Coll, Elisa Pose, et al.. (2022). Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure. JHEP Reports. 4(6). 100482–100482. 19 indexed citations

Campreciós, Genís, Maria Ruart, Carla Montironi, et al.. (2021). Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice. Nutrients. 13(11). 3700–3700. 7 indexed citations

Solé, Cristina, Ann T., Elsa Solà, et al.. (2021). Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome. Liver International. 41(11). 2729–2732. 11 indexed citations

10.

Mezzano, Gabriel, Adrià Juanola, Andrés Cárdenas, et al.. (2021). Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 71(1). 148–155. 129 indexed citations

11.

Mezzano, Gabriel, Andrés Cárdenas, Ferrán Aguilar, et al.. (2021). Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Digestive and Liver Disease. 53(6). 738–745. 5 indexed citations

12.

Bassegoda, Octavi, Patrícia Huelin, Xavier Ariza, et al.. (2020). Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. Journal of Hepatology. 72(6). 1132–1139. 43 indexed citations

13.

Alvarado‐Tápias, Edilmar, Alba Ardèvol, Oana Pavel, et al.. (2020). Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. Journal of Hepatology. 73(4). 829–841. 36 indexed citations

14.

Dayyeh, Barham K. Abu, Fateh Bazerbachi, Isabel Graupera, & Andrés Cárdenas. (2019). Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease. Journal of Hepatology. 71(6). 1246–1248. 21 indexed citations

15.

Solé, Cristina, Elsa Solà, Patrícia Huelin, et al.. (2018). Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival. Liver International. 39(7). 1246–1255. 54 indexed citations

16.

Blaya, Delia, Mar Coll, Daniel Rodrigo‐Torres, et al.. (2016). Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut. 65(9). 1535–1545. 94 indexed citations

17.

Cárdenas, Andrés, Elsa Solà, Ezequiel Rodríguez, et al.. (2014). Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Critical Care. 18(6). 700–700. 31 indexed citations

18.

Puente, Ángela, Virginia Hernández–Gea, Isabel Graupera, et al.. (2013). Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver International. 34(6). 823–833. 84 indexed citations

19.

Fagundes, Cláudia, Eva Rodríguez, Isabel Graupera, et al.. (2013). 1019 URINARY NGAL IS USEFUL TO PREDICT CAUSE AND SEVERITY OF KIDNEY FUNCTION IMPAIRMENT AND IS A PROGNOSTIC MARKER IN PATIENTS HOSPITALIZED FOR COMPLICATIONS OF CIRRHOSIS. Journal of Hepatology. 58. S419–S419. 2 indexed citations

20.

Fagundes, Cláudia, Eva Rodríguez, E. Solà, et al.. (2013). 1018 URINARY KIDNEY INJURY MOLECULE-1 (KIM-1) IN THE ASSESSMENT OF ACUTE KIDNEY INJURY IN PATIENTS WITH CIRRHOSIS. Journal of Hepatology. 58. S419–S419. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact